Brief: Compugen Announces Data Update From COM701 Phase 1 Clinical Trial
25/02/2021 13:34
Feb 25 (Reuters) - Compugen Ltd CGEN.TA :
* COMPUGEN ANNOUNCES DATA UPDATE FROM COM701 PHASE 1
CLINICAL
TRIAL
* COMPUGEN LTD - DURABLE RESPONSES OBSERVED WITH COM701 IN
COMBINATION WITH OPDIVO
* COMPUGEN LTD - RESULTS INCLUDED A CONFIRMED COMPLETE
RESPONSE IN
A PATIENT WITH PRIOR PROGRESSION ON OPDIVO
Source text for Eikon: ID:nPn6rLRbsa
Further company coverage: CGEN.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025